Cited by 145Angiogenesis and VEGF in CancerAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and Metabolism

Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo

Open access
Landskroner-Eiger, Shira, Qian, Binzhi, Muise, Eric S., Nawrocki, Andrea R., Berger, Joel P., Fine, Eugene J., Koba, Wade, Deng, Yingfeng +2 more·2009·Clinical Cancer Research

Published version of a preprint

Abstract

Purpose: Adipocytes represent one of the most abundant constituents of the mammary gland. They are essential for mammary tumor growth and survival. Metabolically, one of the more important fat-derived factors (“adipokines”) is adiponectin (APN). Serum concentrations of APN negatively correlate with body mass index and insulin resistance. To explore the association of APN with breast cancer and tumor angiogenesis, we took an in vivo approach aiming to study its role in the mouse mammary tumor virus (MMTV)-polyoma middle T antigen (PyMT) mammary tumor model. Experimental Design: We compared the rates of tumor growth in MMTV-PyMT mice in wild-type and APN-null backgrounds. Results: Histology and micro-positron emission tomography imaging show that the rate of tumor growth is significantly reduced in the absence of APN at early stages. PyMT/APN knockout mice exhibit a reduction in their angiogenic profile resulting in nutrient deprivation of the tumors and tumor-associated cell death. Surprisingly, in more advanced malignant stages of the disease, tumor growth develops more aggressively in mice lacking APN, giving rise to a larger tumor burden, an increase in the mobilization of circulating endothelial progenitor cells, and a gene expression fingerprint indicative of more aggressive tumor cells. Conclusions: These observations highlight a novel important contribution of APN in mammary tumor development and angiogenesis, indicating that APN has potent angio-mimetic properties in tumor vascularization. However, in tumors deprived of APN, this antiangiogenic stress results in an adaptive response that fuels tumor growth through mobilization of circulating endothelial progenitor cells and the development of mechanisms enabling massive cell proliferation despite a chronically hypoxic microenvironment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-08-2649

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Adiponectin has potent angiomimetic properties in tumor vascularization.

    “Using a genetic approach, our laboratory identified that adiponectin has potent angiomimetic properties in tumor vascularization (75).”

    From Adipose tissue remodeling and obesity (2011) · cites this paper as [75]

  • Adiponectin has been shown to induce angiogenesis in hypoxic fat pads and tumors.

    “Adiponectin, for example, has been shown to induce angiogenesis in hypoxic fat pads and tumors (75,91)”

    From Adipose tissue remodeling and obesity (2011) · cites this paper as [75]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Landskroner-Eiger, S., Qian, B., Muise, E. S., Nawrocki, A. R., Berger, J. P., Fine, E. J., Koba, W., Deng, Y., Pollard, J. W., & Scherer, P. E.
Affiliations
  • 1Cell Biology, Departments of
  • 2Developmental and Molecular Biology, Center of Reproductive Biology and Womens' Health, Albert Einstein Cancer Center, and
  • 4Molecular Profiling and
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Albert Einstein College of Medicine (US)
  • The University of Texas Southwestern Medical Center (US)
Venue
Clinical Cancer Research
Published
2009-05-15
Volume
15
Issue
10
Pages
3265-3276
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2118763988
Cited by
145
References
51
Citations by year
2026: 2 · 2025: 4 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 5 · 2020: 7 · 2019: 7 · 2018: 5 · 2017: 12 · 2016: 7 · 2015: 10 · 2014: 10 · 2013: 23 · 2012: 15
FWCI
6.03
Type
journal article
Language
en
Open access
Locations
  • Clinical Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders
  • National Cancer Institute (R01CA112023)
  • National Institute of General Medical Sciences (T32-GM04791)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
adiponectin, mammary tumor growth, tumor angiogenesis, breast cancer, adipokines, MMTV-PyMT mice, endothelial progenitor cells, tumor hypoxia, tumor microenvironment, tumor vascularization
MeSH terms
Animals, Antigens, Viral, Tumor, Female, Flow Cytometry, Glucose, Male, Mammary Tumor Virus, Mouse, Mammary Neoplasms, Experimental, Mice, Inbred C57BL, Neovascularization, Pathologic, Polyomavirus, Time Factors, Blotting, Western, Gene Expression Regulation, Neoplastic, Apoptosis, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Vascular Endothelial Growth Factor A, Thiazolidinediones, Tumor Burden, PPAR gamma, Positron-Emission Tomography, Mice, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review